VISFO
Success story

Cutting through the noise after FDA approval

Digital analysis revealed the real response to a newly approved drug and identified the voices that mattered most.
Credit card mockupColorful gradient

At a glance

Pharmaceutical

Market Access

Value communication

Initial delivery in 4 weeks

Delivered through HelixAI

Ongoing engagement

"With VISFO’s precision intelligence and collaborative approach, our team ensures you have the right insights, at the right time, to make the best possible strategic decisions."

Dr. Rachael Hagan
Director of Product

“Most teams only see the surface metrics after launch: likes, shares, impressions. But that’s not where strategic insight lives. What made this analysis so powerful was our ability to isolate the authentic signals: who’s shaping the narrative, what topics are resonating, and how sentiment is evolving in real time. That’s what turns digital noise into real competitive advantage.”

Dr. Louise Street-Docherty
VP Strategic Intelligence

“Most teams only see the surface metrics after launch: likes, shares, impressions. But that’s not where strategic insight lives. What made this analysis so powerful was our ability to isolate the authentic signals: who’s shaping the narrative, what topics are resonating, and how sentiment is evolving in real time. That’s what turns digital noise into real competitive advantage.”

Dr. Max Nobile
CEO

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr Adam Poulston
Director of Engineering

“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”

Dr. Simon Leigh
Director of Research & Insights
Cutting through the noise after FDA approval

Built on data, shaped by expertise

Combining sharp data science, deep industry knowledge, and the tools to move fast and make it stick

The challenge

The client had just secured FDA approval for a novel therapy and needed to quickly understand how the market was reacting. While internal teams were preparing sales messaging and conference engagement plans, there was little clarity on how the news was being received online. The client needed to identify which stakeholders were shaping the conversation, how their product was being positioned relative to competitors, and how to turn that intelligence into action.

The analysis

We performed a rapid, targeted digital landscaping exercise. Our team tracked mentions of the drug across social channels, forums, and scientific communities in the immediate aftermath of approval. We segmented the data to focus on a niche subpopulation within a broader therapy area, giving the client clarity on their most relevant audience.

We benchmarked their digital share of voice against key competitors and ran topic analysis to surface the most common themes, pain points, and responses. By mapping both Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs), we identified who was driving the conversation and who could help amplify the client’s message going forward.

The solution

We delivered a tailored digital intelligence report that provided:

  • A breakdown of the client’s impact in the digital space following approval
  • A comparison of engagement and sentiment versus competitor launches
  • A list of high-impact clinicians and organizations active in the online conversation
  • Recommendations for engagement at upcoming conferences and within broader content strategy

The value to the client

The client walked away with a sharper understanding of how their product was being received, which messages were landing, and which voices could help extend their reach. This allowed them to refine their medical and commercial messaging and build more effective stakeholder engagement plans.

Ongoing support

We continue to monitor the conversation and keep the client’s team updated on emerging narratives, stakeholder activity, and changes in sentiment. These insights now support their digital strategy and conference presence across the product lifecycle.

Build your solution

Take a guided walkthrough of how we solve complex challenges, step by step. Just tell us what you’re facing, and we’ll show you how data science, expert insight, and software come together to deliver lasting results.
Dashboard mockupiPhone mockup
Testimonals

What our clients say about us

"This is allowing me to answer questions I didn’t even know I had"
Medical Affairs Director
"I haven't seen anything like it with any other consulting group, ever."
VP Market Access & Reimbursement
"Thank you VISFO, this is incredible value for money"
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs"
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible"
Senior Director
This is allowing me to answer questions I didn’t even know I had!”
Medical Affairs Director
"Thank you VISFO, this is incredible value for money."
Global Market Access Director
"The stakeholder mapping means I know how to resource my MSLs."
US Medical New Product Planning
"You have demonstrated all that I thought wasn’t possible."
Senior Director